Osmotica Pharmaceuticals plc to Present at H.C. Wainwright Bioconnect Conference
Osmotica Pharmaceuticals (Nasdaq: OSMT) announced that CEO Brian Markison, COO James Schaub, and CFO Andrew Einhorn will present at the H.C. Wainwright Bioconnect Conference on January 10, 2022, at 7:00 AM ET. The presentation will be available for on-demand viewing for 30 days via the provided webcast link and the Company’s website. Osmotica focuses on developing pharmaceutical products for underserved markets, with additional operations in Hungary.
- None.
- None.
BRIDGEWATER, N.J., Dec. 20, 2021 (GLOBE NEWSWIRE) -- Osmotica Pharmaceuticals plc (Nasdaq: OSMT) (“Osmotica” or the “Company”), a specialty pharmaceutical company, announced today that Brian Markison, Chief Executive Officer, James “JD” Schaub, Chief Operating Officer, and Andrew Einhorn, Chief Financial Officer, will present virtually at the H.C. Wainwright Bioconnect Conference as follows:
| Date: | Monday, January 10, 2022 |
| On Demand Time: | 7:00AM ET |
| Webcast: | https://journey.ct.events/view/b39a70c0-7058-4a1f-ba97-e18b13918fc7 |
The presentation will be webcast on-demand and available for 30 days thereafter using the link provided above and via the Company’s website at www.osmotica.com under the “Investor & News” section.
About Osmotica Pharmaceuticals plc
Osmotica Pharmaceuticals plc (Nasdaq: OSMT) is a specialty pharmaceutical company focused on the development and commercialization of products that target markets with underserved patient populations. RVL Pharmaceuticals, Inc. is the Company’s ophthalmic subsidiary supporting UPNEEQ®.
Osmotica has operations in the United States and Hungary.
Investor and Media Relations for Osmotica Pharmaceuticals plc
Lisa M. Wilson
In-Site Communications, Inc.
T: 212-452-2793
E: lwilson@insitecony.com
FAQ
When will Osmotica Pharmaceuticals present at the H.C. Wainwright Bioconnect Conference?
Where can I watch the Osmotica Pharmaceuticals conference presentation?
Who are the key executives presenting for Osmotica Pharmaceuticals?
What is the focus of Osmotica Pharmaceuticals?
What is the stock symbol for Osmotica Pharmaceuticals?
